What’s new?
We created a simple mortality score, which is easily calculated and
does not require laboratory and time.
- We created a novel mortality model called Co-AMSCA that included five
parameters, age, male gender, smoking, comorbidity, and using ACE
inhibitor achieved a prediction of mortality in COVID-19 patients who
are hospitalized for pneumonia.
- If the Co-AMSCA score is validated with prospective studies, it can be
used for decreasing mortality and effective utilization of medical
resources in the COVID-19 pandemic.
- Also, we believe that the host risk score we found will be a useful
tool for the prevention and treatment of this disease, in its
detection and more serious follow-up of individuals with high risks.